GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors
Condition(s):Colorectal Cancer; Non-small Cell Lung Cancer; Triple Negative Breast Cancer; Renal Cell Carcinoma; Gastric Cancer; Pancreatic Cancer; Urothelial CancerLast Updated:January 13, 2020Recruiting